Biofunctional technology
for tomorrow's health.

Inspired by Nature. Designed for Impact

NanoMuG develops bioinspired platforms based on mucin nanoparticles, designed to revolutionize drug delivery. An innovative, sustainable, and highly precise approach to improve therapies and open new frontiers in medicine.

Our Direction

Mission & Vision

Mission – We harness nature’s defense mechanisms to create a drug delivery platform built on glycosylated mucin nanoparticles. Our technology optimizes targeting and mucoadhesion, reshaping pharmaceutical development and therapeutic outcomes.

Vision – To become the strategic partner of choice in the pharmaceutical field, offering innovative, high-impact solutions for oncology, infectious diseases, and mucosal health applications. We are committed to relentless innovation that transforms healthcare and improves patients’ lives.

Our Innovation

Mucosomes – A Revolutionary Platform

Mucosomes combine synthesis, encapsulation, and functionalization into a single streamlined process, reducing waste and boosting efficiency. By leveraging the natural properties of mucins, they enhance mucoadhesion, disrupt biofilms, and provide a versatile, scalable solution for advanced therapies.

What Makes Mucosomes Unique

Breakthrough Features

• Bioinspired properties – Natural mucoadhesion and biofilm-disrupting capabilities.
• Advanced targeting – Unique mucin glycosylation enables selective interactions with pathogens.
• Versatility – Capable of encapsulating a wide range of bioactive molecules, from small APIs to proteins.
• Sustainability – Green synthesis using food industry by-products, ensuring scalable and cost-effective production.

About Us

We are NanoMuG

NanoMuG is driven by scientists, researchers, and professionals with expertise in biotechnology, bioengineering, pharmaceutical R&D, and strategic management. A team united by the mission of translating cutting-edge research into real-world healthcare solutions.